ondansetron has been researched along with Claustrophobia in 4 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentagastrin, a cholecystokinin (CCK) agonist, produces anxiety and panic in patients with panic disorder and social phobia." | 9.08 | Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia. ( Geraci, M; McCann, UD; Morgan, CM; Murphy, DL; Post, RM; Slate, SO, 1997) |
| "Pentagastrin, a cholecystokinin (CCK) agonist, produces anxiety and panic in patients with panic disorder and social phobia." | 5.08 | Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia. ( Geraci, M; McCann, UD; Morgan, CM; Murphy, DL; Post, RM; Slate, SO, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SW | 1 |
| Hoover, KM | 1 |
| Schneier, FR | 1 |
| Garfinkel, R | 1 |
| Kennedy, B | 1 |
| Campeas, R | 1 |
| Fallon, B | 1 |
| Marshall, R | 1 |
| O'Donnell, L | 1 |
| Hogan, T | 1 |
| Liebowitz, MR | 1 |
| Tancer, ME | 1 |
| Uhde, TW | 1 |
| McCann, UD | 1 |
| Morgan, CM | 1 |
| Geraci, M | 1 |
| Slate, SO | 1 |
| Murphy, DL | 1 |
| Post, RM | 1 |
1 review available for ondansetron and Claustrophobia
| Article | Year |
|---|---|
Role of serotonin drugs in the treatment of social phobia.
Topics: Buspirone; Clinical Trials as Topic; Double-Blind Method; Fluvoxamine; Humans; Ondansetron; Phobic D | 1997 |
2 trials available for ondansetron and Claustrophobia
| Article | Year |
|---|---|
Tridimensional personality questionnaire: assessment in patients with social phobia and a control group.
Topics: Adult; Anti-Anxiety Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Meth | 1996 |
Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.
Topics: Adult; Behavior; Female; Hemodynamics; Hormones; Humans; Interpersonal Relations; Male; Ondansetron; | 1997 |
1 other study available for ondansetron and Claustrophobia
| Article | Year |
|---|---|
Ondansetron in the treatment of panic disorder.
Topics: Administration, Oral; Adult; Agoraphobia; Female; Humans; Male; Middle Aged; Ondansetron; Panic Diso | 1996 |